Leonteq Securities AG’s Lifecore Biomedical LFCR Stock Holding History

Leonteq Securities AG’s Portfolio LFCR Stock Details LFCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$136	Hold	26	–	–	﹤0.01%	1246
2026 Q1	$97	Hold	26	–	–	﹤0.01%	1257
2025 Q4	$213	Hold	26	–	–	﹤0.01%	1394
2025 Q3	$191	Hold	26	–	–	﹤0.01%	1291
2025 Q2	$211	Hold	26	–	–	﹤0.01%	1235
2025 Q1	$183	Hold	26	–	–	﹤0.01%	1199
2024 Q4	$193	Hold	26	–	–	﹤0.01%	1221
2024 Q3	$128	Hold	26	–	–	﹤0.01%	1174
2024 Q2	$133	Hold	26	–	–	﹤0.01%	1173
2024 Q1	$138	Hold	26	–	–	﹤0.01%	1182
2023 Q4	$161	Hold	26	–	–	﹤0.01%	1171
2023 Q3	$196	Hold	26	–	–	﹤0.01%	1179
2023 Q2	$251	Hold	26	–	–	﹤0.01%	1198
2023 Q1	$98	Hold	26	–	–	﹤0.01%	1180
2022 Q4	$168	Hold	26	–	–	﹤0.01%	1253
2022 Q3	$231	Hold	26	–	–	﹤0.01%	1242
2022 Q2	$259	Buy	+26	New	+$257	﹤0.01%	1245

Other funds holding LFCR

Wynnefield Capital New York $145M AUM 14.57% 1-Year Est. Return

LPAM

Legion Partners Asset Management Los Angeles, California $40.6M AUM 156.55% 1-Year Est. Return

GRIM

Greenhaven Road Investment Management Greenwich, Connecticut $154M AUM 15.9% 1-Year Est. Return

325 Capital New York $419M AUM 75.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

QOP

Quinn Opportunity Partners Charlottesville, Virginia $2.16B AUM 28.56% 1-Year Est. Return

Leonteq Securities AG's LFCR Position: Q2 2026 in Review

Leonteq Securities AG held its Lifecore Biomedical (LFCR) position steady in Q2 2026 at 26 shares worth $136. The position accounts for ﹤0.01% of the portfolio, ranked #1246.

Leonteq Securities AG first reported a position in LFCR in Q2 2022 and has held it in 17 quarters since. The position peaked at $259 in Q2 2022. 99 funds tracked by Wall St. Rank hold LFCR as of Q2 2026.

Leonteq Securities AG held 26 shares of Lifecore Biomedical worth $136 as of Q2 2026.
Leonteq Securities AG left its Lifecore Biomedical share count unchanged in Q2 2026.
Lifecore Biomedical made up ﹤0.01% of Leonteq Securities AG's portfolio in Q2 2026, its #1246 holding.
Leonteq Securities AG first reported a position in Lifecore Biomedical in Q2 2022 and has held it in 17 quarters since.
Leonteq Securities AG's Lifecore Biomedical position peaked at $259 in Q2 2022.
99 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q2 2026.

Based on Leonteq Securities AG's 13F filing for Q2 2026, filed 27 Jul 2026.